Monoclonal antibody combo keeps high-risk COVID-19 patients out of hospital

Treatment with two monoclonal antibodies lowers the odds of hospitalization for high-risk COVID-19 patients with mild to moderate illness, according to a new study.

from Latest News - UPI.com https://ift.tt/3t2o3kQ
via IFTTT